<DOC>
	<DOCNO>NCT01685424</DOCNO>
	<brief_summary>This postmarketing study conduct describe prescribing pattern etoricoxib ( ARCOXIAÂ® ) General Practice describe incidence select adverse event record United Kingdom ( UK ) Medicines Health Care Products Regulatory Agency ( MHRA ) General Practice Research Database ( GPRD ) .</brief_summary>
	<brief_title>Etoricoxib Prescribing Patterns Adverse Events Interest Primary Care United Kingdom ( MK-0663-162 AM1 )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Etoricoxib</mesh_term>
	<criteria>All patient MHRA 's Full Feature GPRD ( FFGPRD ) least one electronic outpatient prescription record etoricoxib issue General Practitioner period ( April 1 , 2002 December 31 , 2015 ) date query execution FFGPRD data warehouse . Not registered GPRDcontributing practice continuously collect data deem 'uptostandard ' research purpose 1 April 2002 31 December 2015 . Never register permanent patient General Practitioner practice Registration detail acceptable ( i.e . incomplete data logically implausible date ) Not register General Practitioner least 365 day date patient 's first etoricoxib prescription record GPRD</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Etoricoxib</keyword>
	<keyword>ARCOXIA</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Ankylosing Spondylitis</keyword>
	<keyword>Gout</keyword>
	<keyword>Arthritis</keyword>
</DOC>